bicalutamide and casein kinase ii

bicalutamide has been researched along with casein kinase ii in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Deng, C; Guo, S; Han, H; Li, Z; Wang, Y; Yang, X; Yao, K; Yu, X; Zhang, Z; Zhou, F; Zhou, Q	1

Other Studies

1 other study(ies) available for bicalutamide and casein kinase ii

Article	Year
CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression. World journal of urology, 2017, Volume: 35, Issue:8 Topics: Androgen Antagonists; Anilides; Blotting, Western; Casein Kinase II; Cell Line, Tumor; Drug Resistance, Neoplasm; Genetic Variation; Humans; Male; Naphthyridines; NF-kappa B; NF-kappa B p50 Subunit; Nitriles; Phenazines; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; RNA, Messenger; Signal Transduction; Tosyl Compounds; Transcription Factor RelA; Tumor Stem Cell Assay	2017

Article

Year

CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression.

World journal of urology, 2017, Volume: 35, Issue:8

Topics: Androgen Antagonists; Anilides; Blotting, Western; Casein Kinase II; Cell Line, Tumor; Drug Resistance, Neoplasm; Genetic Variation; Humans; Male; Naphthyridines; NF-kappa B; NF-kappa B p50 Subunit; Nitriles; Phenazines; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; RNA, Messenger; Signal Transduction; Tosyl Compounds; Transcription Factor RelA; Tumor Stem Cell Assay

2017